Medication Guide - 3/26/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Pegasys Peginterferon Alfa-2a SYRINGE 103964 HOFFMAN-LA ROCHE 03/24/2021 Pegasys Peginterferon Alfa-2a VIAL; SUBCUTANEOUS 103964 HOFFMAN-LA ROCHE 03/24/2021 Triumeq Abacavir Sulfate; Dolutegravir Sodium; LAmivudine TABLET;ORAL 205551 VIIV HLTHCARE 03/23/2021 Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 03/22/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA